These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 1431243

  • 1. Regulation of complement activity by vaccinia virus complement-control protein.
    McKenzie R, Kotwal GJ, Moss B, Hammer CH, Frank MM.
    J Infect Dis; 1992 Dec; 166(6):1245-50. PubMed ID: 1431243
    [Abstract] [Full Text] [Related]

  • 2. Interaction of vaccinia virus complement control protein with human complement proteins: factor I-mediated degradation of C3b to iC3b1 inactivates the alternative complement pathway.
    Sahu A, Isaacs SN, Soulika AM, Lambris JD.
    J Immunol; 1998 Jun 01; 160(11):5596-604. PubMed ID: 9605165
    [Abstract] [Full Text] [Related]

  • 3. Identification of complement regulatory domains in vaccinia virus complement control protein.
    Mullick J, Bernet J, Panse Y, Hallihosur S, Singh AK, Sahu A.
    J Virol; 2005 Oct 01; 79(19):12382-93. PubMed ID: 16160165
    [Abstract] [Full Text] [Related]

  • 4. Species Specificity of Vaccinia Virus Complement Control Protein for the Bovine Classical Pathway Is Governed Primarily by Direct Interaction of Its Acidic Residues with Factor I.
    Kumar J, Yadav VN, Phulera S, Kamble A, Gautam AK, Panwar HS, Sahu A.
    J Virol; 2017 Oct 01; 91(19):. PubMed ID: 28724763
    [Abstract] [Full Text] [Related]

  • 5. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
    Ollert MW, Kadlec JV, Petrella EC, Bredehorst R, Vogel CW.
    Cancer Res; 1993 Feb 01; 53(3):592-9. PubMed ID: 8425193
    [Abstract] [Full Text] [Related]

  • 6. Vaccinia virus complement-control protein prevents antibody-dependent complement-enhanced neutralization of infectivity and contributes to virulence.
    Isaacs SN, Kotwal GJ, Moss B.
    Proc Natl Acad Sci U S A; 1992 Jan 15; 89(2):628-32. PubMed ID: 1731333
    [Abstract] [Full Text] [Related]

  • 7. Covalent association of C3b with C4b within C5 convertase of the classical complement pathway.
    Takata Y, Kinoshita T, Kozono H, Takeda J, Tanaka E, Hong K, Inoue K.
    J Exp Med; 1987 Jun 01; 165(6):1494-507. PubMed ID: 3495629
    [Abstract] [Full Text] [Related]

  • 8. The low C5 convertase activity of the C4A6 allotype of human complement component C4.
    Kinoshita T, Dodds AW, Law SK, Inoue K.
    Biochem J; 1989 Aug 01; 261(3):743-8. PubMed ID: 2803239
    [Abstract] [Full Text] [Related]

  • 9. Modulation of the classical pathway C3 convertase by plasma proteins C4 binding protein and C3b inactivator.
    Gigli I, Fujita T, Nussenzweig V.
    Proc Natl Acad Sci U S A; 1979 Dec 01; 76(12):6596-600. PubMed ID: 293746
    [Abstract] [Full Text] [Related]

  • 10. Restoration of complement-enhanced neutralization of vaccinia virus virions by novel monoclonal antibodies raised against the vaccinia virus complement control protein.
    Isaacs SN, Argyropoulos E, Sfyroera G, Mohammad S, Lambris JD.
    J Virol; 2003 Aug 01; 77(15):8256-62. PubMed ID: 12857894
    [Abstract] [Full Text] [Related]

  • 11. Mechanism of action of the C4 nephritic factor. Deregulation of the classical pathway of C3 convertase.
    Gigli I, Sorvillo J, Mecarelli-Halbwachs L, Leibowitch J.
    J Exp Med; 1981 Jul 01; 154(1):1-12. PubMed ID: 7019379
    [Abstract] [Full Text] [Related]

  • 12. Role of membrane cofactor protein (CD46) in regulation of C4b and C3b deposited on cells.
    Barilla-LaBarca ML, Liszewski MK, Lambris JD, Hourcade D, Atkinson JP.
    J Immunol; 2002 Jun 15; 168(12):6298-304. PubMed ID: 12055245
    [Abstract] [Full Text] [Related]

  • 13. Kinetic analysis of the interactions between vaccinia virus complement control protein and human complement proteins C3b and C4b.
    Bernet J, Mullick J, Panse Y, Parab PB, Sahu A.
    J Virol; 2004 Sep 15; 78(17):9446-57. PubMed ID: 15308738
    [Abstract] [Full Text] [Related]

  • 14. Alternative complement pathway activation by C4b deposited during classical pathway activation.
    Matsushita M, Okada H.
    J Immunol; 1986 Apr 15; 136(8):2994-8. PubMed ID: 2937839
    [Abstract] [Full Text] [Related]

  • 15. Protection of the classical and alternative complement pathway C3 convertases, stabilized by nephritic factors, from decay by the human C3b receptor.
    Fischer E, Kazatchkine MD, Mecarelli-Halbwachs L.
    Eur J Immunol; 1984 Dec 15; 14(12):1111-4. PubMed ID: 6240408
    [Abstract] [Full Text] [Related]

  • 16. Covalent binding of C3b to C4b within the classical complement pathway C5 convertase. Determination of amino acid residues involved in ester linkage formation.
    Kim YU, Carroll MC, Isenman DE, Nonaka M, Pramoonjago P, Takeda J, Inoue K, Kinoshita T.
    J Biol Chem; 1992 Feb 25; 267(6):4171-6. PubMed ID: 1740458
    [Abstract] [Full Text] [Related]

  • 17. Regulation and deregulation of the fluid-phase classical pathway C3 convertase.
    Gigli I, Sorvillo J, Halbwachs-Mecarelli L.
    J Immunol; 1985 Jul 25; 135(1):440-4. PubMed ID: 3158705
    [Abstract] [Full Text] [Related]

  • 18. Complement receptor is an inhibitor of the complement cascade.
    Iida K, Nussenzweig V.
    J Exp Med; 1981 May 01; 153(5):1138-50. PubMed ID: 6910481
    [Abstract] [Full Text] [Related]

  • 19. A mechanism of activation of the alternative complement pathway by the classical pathway: protection of C3b from inactivation by covalent attachment to C4b.
    Meri S, Pangburn MK.
    Eur J Immunol; 1990 Dec 01; 20(12):2555-61. PubMed ID: 2148521
    [Abstract] [Full Text] [Related]

  • 20. Structure and regulatory profile of the monkeypox inhibitor of complement: comparison to homologs in vaccinia and variola and evidence for dimer formation.
    Liszewski MK, Leung MK, Hauhart R, Buller RM, Bertram P, Wang X, Rosengard AM, Kotwal GJ, Atkinson JP.
    J Immunol; 2006 Mar 15; 176(6):3725-34. PubMed ID: 16517741
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.